Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otitis Media with Effusion | 4 | 2019 | 115 | 2.070 |
Why?
|
Histamine Antagonists | 3 | 2019 | 93 | 1.330 |
Why?
|
Nasal Polyps | 7 | 2023 | 395 | 1.010 |
Why?
|
Steroids | 2 | 2019 | 929 | 0.850 |
Why?
|
Rhinitis | 7 | 2023 | 747 | 0.840 |
Why?
|
Administration, Intranasal | 3 | 2022 | 476 | 0.760 |
Why?
|
Vestibule, Labyrinth | 2 | 2012 | 234 | 0.680 |
Why?
|
Sinusitis | 6 | 2023 | 990 | 0.660 |
Why?
|
Semicircular Canals | 2 | 2012 | 203 | 0.640 |
Why?
|
Asthma, Aspirin-Induced | 4 | 2023 | 202 | 0.630 |
Why?
|
Ear Neoplasms | 2 | 2024 | 118 | 0.620 |
Why?
|
Motion Perception | 2 | 2012 | 374 | 0.610 |
Why?
|
Otitis Media | 1 | 2018 | 286 | 0.530 |
Why?
|
Sensory Thresholds | 2 | 2012 | 377 | 0.450 |
Why?
|
Hearing Loss | 4 | 2018 | 782 | 0.430 |
Why?
|
Vestibular Function Tests | 2 | 2012 | 128 | 0.420 |
Why?
|
Zygoma | 1 | 2012 | 52 | 0.390 |
Why?
|
Ear Canal | 1 | 2012 | 149 | 0.390 |
Why?
|
Epidermal Cyst | 1 | 2012 | 64 | 0.380 |
Why?
|
Proprioception | 1 | 2012 | 132 | 0.360 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7407 | 0.300 |
Why?
|
Quality Improvement | 3 | 2017 | 3808 | 0.270 |
Why?
|
Vestibular Diseases | 1 | 2009 | 231 | 0.270 |
Why?
|
Evoked Potentials, Auditory | 1 | 2009 | 531 | 0.260 |
Why?
|
Functional Laterality | 1 | 2012 | 2257 | 0.250 |
Why?
|
Cochlear Implantation | 1 | 2009 | 316 | 0.240 |
Why?
|
Cochlear Implants | 1 | 2009 | 339 | 0.240 |
Why?
|
Speech | 1 | 2009 | 554 | 0.230 |
Why?
|
Adenocarcinoma, Sebaceous | 1 | 2024 | 21 | 0.230 |
Why?
|
Ear, Middle | 2 | 2024 | 341 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Olfactory Mucosa | 1 | 2024 | 101 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Nasal Mucosa | 2 | 2024 | 413 | 0.190 |
Why?
|
Mast Cells | 2 | 2023 | 1392 | 0.160 |
Why?
|
Adenoids | 1 | 2018 | 35 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1071 | 0.160 |
Why?
|
Cryopreservation | 1 | 2023 | 728 | 0.150 |
Why?
|
Leukotriene Antagonists | 1 | 2016 | 124 | 0.130 |
Why?
|
Hearing Tests | 1 | 2016 | 121 | 0.130 |
Why?
|
Mucins | 1 | 2018 | 569 | 0.120 |
Why?
|
Anti-Allergic Agents | 1 | 2016 | 153 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1167 | 0.120 |
Why?
|
Models, Statistical | 1 | 2009 | 5081 | 0.120 |
Why?
|
Inappropriate Prescribing | 1 | 2017 | 212 | 0.120 |
Why?
|
Melanoma | 1 | 2012 | 5694 | 0.110 |
Why?
|
Eosinophilia | 1 | 2018 | 557 | 0.110 |
Why?
|
Chronic Disease | 6 | 2023 | 9319 | 0.110 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2012 | 11 | 0.110 |
Why?
|
Immune System | 1 | 2018 | 792 | 0.110 |
Why?
|
Interleukin-5 | 2 | 2023 | 266 | 0.100 |
Why?
|
Hearing Loss, Bilateral | 1 | 2012 | 53 | 0.100 |
Why?
|
Humans | 27 | 2024 | 761208 | 0.100 |
Why?
|
Male | 16 | 2024 | 360693 | 0.100 |
Why?
|
Asperger Syndrome | 1 | 2012 | 57 | 0.100 |
Why?
|
Acoustic Impedance Tests | 1 | 2012 | 111 | 0.100 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2012 | 187 | 0.090 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 573 | 0.090 |
Why?
|
Aspirin | 4 | 2023 | 3129 | 0.090 |
Why?
|
Interleukin-13 | 2 | 2023 | 392 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18384 | 0.090 |
Why?
|
Rotation | 1 | 2012 | 517 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2425 | 0.080 |
Why?
|
Neurofibromatosis 2 | 1 | 2012 | 383 | 0.080 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1723 | 0.080 |
Why?
|
Reflex, Vestibulo-Ocular | 1 | 2009 | 86 | 0.080 |
Why?
|
Neck Muscles | 1 | 2009 | 100 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4574 | 0.080 |
Why?
|
Bone Conduction | 1 | 2009 | 102 | 0.080 |
Why?
|
Female | 14 | 2024 | 392544 | 0.080 |
Why?
|
Adult | 11 | 2023 | 221119 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4015 | 0.070 |
Why?
|
Speech Perception | 1 | 2012 | 508 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2024 | 10422 | 0.070 |
Why?
|
Epithelial Cells | 3 | 2024 | 3671 | 0.070 |
Why?
|
Temporal Bone | 1 | 2012 | 683 | 0.070 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2012 | 781 | 0.070 |
Why?
|
Middle Aged | 9 | 2024 | 220853 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2012 | 1984 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9187 | 0.060 |
Why?
|
United States | 4 | 2017 | 72339 | 0.060 |
Why?
|
Area Under Curve | 1 | 2009 | 1636 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26071 | 0.060 |
Why?
|
Child | 4 | 2017 | 80152 | 0.060 |
Why?
|
Acoustic Stimulation | 1 | 2009 | 1240 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2009 | 1200 | 0.060 |
Why?
|
Electromyography | 1 | 2009 | 1393 | 0.060 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2024 | 40 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 140 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2854 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3271 | 0.050 |
Why?
|
Muromonab-CD3 | 1 | 2022 | 104 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2020 | 80674 | 0.050 |
Why?
|
Asthma | 1 | 2020 | 6230 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 456 | 0.050 |
Why?
|
ROC Curve | 1 | 2009 | 3584 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2451 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 2067 | 0.040 |
Why?
|
Research Subjects | 1 | 2022 | 249 | 0.040 |
Why?
|
Coronaviridae Infections | 1 | 2020 | 10 | 0.040 |
Why?
|
Mass Screening | 1 | 2016 | 5426 | 0.040 |
Why?
|
Aged | 6 | 2024 | 169288 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Encephalitis, Viral | 1 | 2020 | 58 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7400 | 0.040 |
Why?
|
Viral Tropism | 1 | 2020 | 101 | 0.040 |
Why?
|
Recurrence | 1 | 2012 | 8457 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 836 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2023 | 1154 | 0.040 |
Why?
|
Cytokines | 2 | 2024 | 7386 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 224 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 59221 | 0.040 |
Why?
|
Iran | 1 | 2020 | 736 | 0.040 |
Why?
|
Rhinoplasty | 1 | 2020 | 238 | 0.030 |
Why?
|
Child, Preschool | 2 | 2016 | 42224 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2011 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1751 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13367 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36415 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2020 | 709 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8702 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15308 | 0.030 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.030 |
Why?
|
Mice | 3 | 2024 | 81326 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2016 | 762 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3594 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 14025 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2277 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1852 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2871 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2021 | 5871 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3092 | 0.020 |
Why?
|
Perception | 1 | 2016 | 1198 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20588 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 18926 | 0.020 |
Why?
|
Adolescent | 2 | 2016 | 88298 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168079 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11509 | 0.020 |
Why?
|
Health Surveys | 1 | 2016 | 4037 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9652 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2009 | 58952 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10759 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7804 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13249 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7966 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23416 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15841 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21365 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15637 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24021 | 0.010 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_